Evolus, Inc. (EOLS)
Total Valuation
Evolus has a market cap or net worth of $860.97 million. The enterprise value is $924.67 million.
Market Cap | 860.97M |
Enterprise Value | 924.67M |
Important Dates
The last earnings date was Thursday, March 7, 2024, after market close.
Earnings Date | Mar 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Evolus has 61.50 million shares outstanding. The number of shares has increased by 1.52% in one year.
Shares Outstanding | 61.50M |
Shares Change (YoY) | +1.52% |
Shares Change (QoQ) | +0.40% |
Owned by Insiders (%) | 13.06% |
Owned by Institutions (%) | 76.86% |
Float | 38.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.26 |
Forward PS | 3.24 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.58 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33
Current Ratio | 2.33 |
Quick Ratio | 1.93 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.45 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -36.00% |
Return on Capital (ROIC) | -46.51% |
Revenue Per Employee | $740,238 |
Profits Per Employee | -$225,952 |
Employee Count | 273 |
Asset Turnover | 1.18 |
Inventory Turnover | 4.12 |
Taxes
In the past 12 months, Evolus has paid $176,000 in taxes.
Income Tax | 176,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.52% in the last 52 weeks. The beta is 1.46, so Evolus's price volatility has been higher than the market average.
Beta (1Y) | 1.46 |
52-Week Price Change | +70.52% |
50-Day Moving Average | 13.53 |
200-Day Moving Average | 10.11 |
Relative Strength Index (RSI) | 53.71 |
Average Volume (30 Days) | 664,059 |
Short Selling Information
The latest short interest is 4.98 million, so 8.09% of the outstanding shares have been sold short.
Short Interest | 4.98M |
Short Previous Month | 4.96M |
Short % of Shares Out | 8.09% |
Short % of Float | 12.82% |
Short Ratio (days to cover) | 7.50 |
Income Statement
In the last 12 months, Evolus had revenue of $202.09 million and -$61.69 million in losses. Loss per share was -$1.08.
Revenue | 202.09M |
Gross Profit | 140.53M |
Operating Income | -49.23M |
Pretax Income | -61.51M |
Net Income | -61.69M |
EBITDA | -41.81M |
EBIT | -47.68M |
Loss Per Share | -$1.08 |
Balance Sheet
The company has $62.84 million in cash and $126.55 million in debt, giving a net cash position of -$63.71 million or -$1.04 per share.
Cash & Cash Equivalents | 62.84M |
Total Debt | 126.55M |
Net Cash | -63.71M |
Net Cash Per Share | -$1.04 |
Equity / Book Value | -20.69M |
Book Value Per Share | -0.34 |
Working Capital | 64.13M |
Cash Flow
In the last 12 months, operating cash flow was -$34.01 million and capital expenditures -$1.63 million, giving a free cash flow of -$35.64 million.
Operating Cash Flow | -34.01M |
Capital Expenditures | -1.63M |
Free Cash Flow | -35.64M |
FCF Per Share | -$0.63 |
Margins
Gross margin is 69.54%, with operating and profit margins of -24.36% and -30.52%.
Gross Margin | 69.54% |
Operating Margin | -24.36% |
Pretax Margin | -30.44% |
Profit Margin | -30.52% |
EBITDA Margin | -20.69% |
EBIT Margin | -23.59% |
FCF Margin | -17.63% |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.52% |
Shareholder Yield | -1.52% |
Earnings Yield | -7.16% |
FCF Yield | -4.14% |
Analyst Forecast
The average price target for Evolus is $21.83, which is 55.93% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.83 |
Price Target Difference | 55.93% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 27.36% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -1.03 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.03 |
Piotroski F-Score | 4 |